Abstract:Over the last decade, hydrogen sulfide (H2S) has emerged as an important endogenous gasotransmitter in mammalian cells and tissues. Similar to the previously characterized gasotransmitters nitric oxide and carbon monoxide, H2S is produced by various enzymatic reactions and regulates a host of physiologic and pathophysiological processes in various cells and tissues. H2S levels are decreased in a number of conditions (e.g., diabetes mellitus, ischemia, and aging) and are increased in other states (e.g., inflammation, critical illness, and cancer). Over the last decades, multiple approaches have been identified for the therapeutic exploitation of H2S, either based on H2S donation or inhibition of H2S biosynthesis. H2S donation can be achieved through the inhalation of H2S gas and/or the parenteral or enteral administration of so-called fast-releasing H2S donors (salts of H2S such as NaHS and Na2S) or slow-releasing H2S donors (GYY4137 being the prototypical compound used in hundreds of studies in vitro and in vivo). Recent work also identifies various donors with regulated H2S release profiles, including oxidant-triggered donors, pH-dependent donors, esterase-activated donors, and organelle-targeted (e.g., mitochondrial) compounds. There are also approaches where existing, clinically approved drugs of various classes (e.g., nonsteroidal anti-inflammatories) are coupled with H2S-donating groups (the most advanced compound in clinical trials is ATB-346, an H2S-donating derivative of the non-steroidal anti-inflammatory compound naproxen). For pharmacological inhibition of H2S synthesis, there are now several small molecule compounds targeting each of the three H2S-producing enzymes cystathionine-β-synthase (CBS), cystathionine-γ-lyase, and 3-mercaptopyruvate sulfurtransferase. Although many of these compounds have their limitations (potency, selectivity), these molecules, especially in combination with genetic approaches, can be instrumental for the delineation of the biologic processes involving endogenous H2S production. Moreover, some of these compounds (e.g., cell-permeable prodrugs of the CBS inhibitor aminooxyacetate, or benserazide, a potentially repurposable CBS inhibitor) may serve as starting points for future clinical translation. The present article overviews the currently known H2S donors and H2S biosynthesis inhibitors, delineates their mode of action, and offers examples for their biologic effects and potential therapeutic utility.

S-Se-S Type Molecule: A Bactericidal Promoter Against H<sub>2</sub>S-induced Antibiotic Resistance

H 2 S scavenger as a broad-spectrum strategy to deplete bacteria-derived H 2 S for antibacterial sensitization

Endogenous production and physiological functions of hydrogen sulfide in facultative anaerobic bacteria

Surface Chemistry Engineered Selenium Nanoparticles as Bactericidal and Immuno-modulating Dual-functional Agents for Combating Methicillin-resistant Staphylococcus aureus Infection

Sulfur (SVI)-containing heterocyclic hybrids as antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA) and its SAR

Diffusible signal factor (DSF) quorum sensing signal and structurally related molecules enhance the antimicrobial efficacy of antibiotics against some bacterial pathogens

Cell‐Penetrating Peptide Induced Superstructures Triggering Highly Efficient Antibacterial Activity

Cysteine-Activated Small-Molecule H2Se Donors Inspired by Synthetic H2S Donors

Hydrogen sulfide production does not affect antibiotic resistance in Pseudomonas aeruginosa

Antibacterial Activity of Squaric Amide Derivative SA2 against Methicillin-Resistant Staphylococcus aureus

Metabolic and Structural Insights into Hydrogen Sulfide Mis-Regulation in Enterococcus faecalis

Secnidazole Is a Promising Imidazole Mitigator of Serratia marcescens Virulence

A Methylazanediyl Bisacetamide Derivative Sensitizes Staphylococcus Aureus Persisters to a Combination of Gentamicin and Daptomycin.

Converting organosulfur compounds to inorganic polysulfides against resistant bacterial infections

Inhibitors of the sulfur assimilation pathway in bacterial pathogens as enhancers of antibiotic therapy

International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H2S Levels: H2S Donors and H2S Biosynthesis Inhibitors

High antibacterial activity of chitosan - molybdenum disulfide nanocomposite.

Insights into small-molecule compound CY-158-11 antibacterial activity against Staphylococcus aureus

A Common Molecular Switch for H2S to Regulate Multiple Protein Targets

A Homing Missile‐Like Nanotherapeutic with Single‐Atom Catalytic Sites for In Situ Elimination of Intracellular Bacterial Pathogens

Hydrogen Sulfide is A Novel Mediator of Lipopolysaccharide-Induced Inflammation in the Mouse

S-Se-S Type Molecule: A Bactericidal Promoter Against H&lt;sub&gt;2&lt;/sub&gt;S-induced Antibiotic Resistance